Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion - Moreland, LW; Alten, R; Van den Bosch, F (Arthritis Rheum, 2002)
et al.